Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cureus|August 27, 2025
Short Supply-Driven Modifications to Blood Culture Practice and Their Clinical Impact: A Single-Center Time-Series StudyDaisuke Ono, Kazuyuki Mimura, Yuki Watanabe, et al.
Heart and Vessels|February 27, 2024
Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational studyHiroshi Ueda, Yoshihiro Fujiwara, Yusuke Nishida, et al.
Internal Medicine (Tokyo, Japan)|January 17, 2014
Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devicesNatsuko Yoshimizu, Tomo Tominaga, Takahide Ito, et al.
Influenza and Other Respiratory Viruses|April 26, 2022
Behavioral factors associated with SARS-CoV-2 infection in JapanTakeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)Takeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, et al.
Open Forum Infectious Diseases|June 23, 2023
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in JapanTakeshi Arashiro, Yuzo Arima, Jin Kuramochi, et al.
Vaccine|October 15, 2023
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in JapanTakeshi Arashiro, Yuzo Arima, Jin Kuramochi, et al.
Vaccine|December 19, 2023
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, et al.
Pageof 8